| Oct 1, 2025 |
Oct 3, 2025 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
92.5
|
+1,446
|
5.56%
|
✗
|
$635.1K |
| Aug 29, 2025 |
Sep 2, 2025 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
20.0
|
-3,474
|
-11.79%
|
✓
|
$1.6M |
| Aug 15, 2025 |
Aug 19, 2025 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
92.5
|
+1,455
|
5.19%
|
✗
|
$632.8K |
| Mar 3, 2025 |
Mar 5, 2025 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
95.0
|
+13,666
|
95.27%
|
✗
|
$114.8K |
| Feb 27, 2025 |
Mar 3, 2025 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
42.5
|
-513
|
-3.45%
|
✗
|
$124K |
| Nov 25, 2024 |
Nov 27, 2024 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
97.5
|
+1,531
|
13.13%
|
✗
|
$368.7K |
| Jun 24, 2024 |
Jun 26, 2024 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
97.5
|
+1,673
|
16.75%
|
✗
|
$370.7K |
| Feb 27, 2024 |
Feb 29, 2024 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
42.5
|
-501
|
-8.73%
|
✗
|
$77.8K |
| Feb 15, 2024 |
Feb 20, 2024 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
95.0
|
+2,269
|
125.99%
|
✗
|
$149.4K |
| Apr 26, 2023 |
Apr 28, 2023 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
97.5
|
+1,801
|
100.00%
|
✗
|
$287.2K |
| Feb 1, 2023 |
Feb 3, 2023 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
5.0
|
-5,025
|
-100.00%
|
✓
|
$1.2M |
| Aug 3, 2022 |
Aug 5, 2022 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
5.0
|
-1,754
|
-100.00%
|
✓
|
$1.1M |
| Jul 5, 2022 |
Jul 7, 2022 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
7.5
|
-1,754
|
-50.00%
|
✓
|
$263.1K |
| Feb 1, 2022 |
Feb 3, 2022 |
ALNYLAM PHARMACEUTICALS, INC.
|
EVP, Chief Commercial Officer |
Sell |
42.5
|
-1,518
|
-30.20%
|
✗
|
$219.6K |